OXTENDA ODR Trademark

Trademark Overview


On Monday, September 15, 2014, a trademark application was filed for OXTENDA ODR with the United States Patent and Trademark Office. The USPTO has given the OXTENDA ODR trademark a serial number of 86394998. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, February 4, 2017. This trademark is owned by Intellipharmaceutics Corp.. The OXTENDA ODR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis

Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations
oxtenda odr

General Information


Serial Number86394998
Word MarkOXTENDA ODR
Filing DateMonday, September 15, 2014
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, February 4, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis
Goods and ServicesResearch and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations
Translation of Words in MarkThe wording "OXTENDA ODR" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 22, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 22, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIntellipharmaceutics Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M9W5X2
CA

Trademark Events


Event DateEvent Description
Monday, February 6, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, February 4, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, July 8, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 8, 2016NON-FINAL ACTION E-MAILED
Friday, July 8, 2016NON-FINAL ACTION WRITTEN
Sunday, June 5, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, June 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 25, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, May 10, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 10, 2016LETTER OF SUSPENSION E-MAILED
Tuesday, May 10, 2016SUSPENSION LETTER WRITTEN
Saturday, April 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 13, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, January 26, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, January 26, 2016INQUIRY TO SUSPENSION E-MAILED
Tuesday, January 26, 2016SUSPENSION INQUIRY WRITTEN
Friday, January 8, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, July 8, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 8, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, July 8, 2015SUSPENSION LETTER WRITTEN
Tuesday, June 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 29, 2015ASSIGNED TO LIE
Friday, May 22, 2015ASSIGNED TO LIE
Thursday, May 21, 2015NOTICE OF REVIVAL - E-MAILED
Wednesday, May 20, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 20, 2015PETITION TO REVIVE-GRANTED
Wednesday, May 20, 2015TEAS PETITION TO REVIVE RECEIVED
Tuesday, November 4, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 4, 2014NON-FINAL ACTION E-MAILED
Tuesday, November 4, 2014NON-FINAL ACTION WRITTEN
Tuesday, October 28, 2014ASSIGNED TO EXAMINER
Monday, September 22, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 18, 2014NEW APPLICATION ENTERED IN TRAM